Life sciences companies presenting at CED’s Life Science Conference largely stuck to script. Prepared remarks. PowerPoint presentations. After 11 minutes on stage, another presenter took their place. Immunotherapy company Heat Biologics broke from script and announced a $10 million series B round to complete one mid-stage study on its lead treatment candidate and two early […]
Vaccine technology company Heat Biologics has come into more money to help pay for clinical trials for its novel cancer-fighting immunotherapy. The North Carolina Biotechnology Center awarded the biotechnology company a $250,000 loan to cover some of the company’s trial expenses. Chapel Hill, North Carolina-based Heat is in the midst of a fundraising round expected […]
AI-native tax firm Gelt combines top human tax experts with AI to help physicians and healthcare practices use data-driven tax strategies to lower liabilities, improve profitability, and future-proof their finances.
Heat Biologics, already in phase 2 clinical trials with an experimental treatment for nonsmall cell lung cancer, is readying to study its immunotherapy technology in additional cancers. The Chapel Hill, North Carolina company is more than halfway through a $4.1 million fundraising round to help that effort. Securities filings show that Heat Biologics has raised […]